NCT02233244View on ClinicalTrials.gov

Drug-Drug Interaction Study to Evaluate the Pharmacokinetics and Safety of CTX 4430 and Midazolam

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Healthy

Interventions

DRUG

CTX-4430

DRUG

Midazolam

Trial Locations (1)

BT9 6AD

Celerion, Belfast

Sponsors

Lead Sponsor

Celtaxsys, Inc.

All Listed Sponsors

lead

Celtaxsys, Inc.

OTHER

NCT02233244 - Drug-Drug Interaction Study to Evaluate the Pharmacokinetics and Safety of CTX 4430 and Midazolam | Biotech Hunter | Biotech Hunter